Transcatheter Aortic Valve Replacement (TAVR) is a less invasive procedure that replaces the diseased aortic valve without opening your chest to reach your heart. TAVR can save lives and significantly improve quality of life, but like all medical procedures, it may involve risk. The Cerebral Protection Devices (CPD) is the device to offer patient protection from the risk of stroke during TAVR. It works by capturing embolic debris dislodged during TAVR before it can reach the brain.However, Cerebral Embolic Protection Devices for TAVR is still in the early stage of development, most companies are not commercialized, and the market fluctuates greatly.
This report contains market size and forecasts of Cerebral Embolic Protection Devices for TAVR in global, including the following market information:
Global Cerebral Embolic Protection Devices for TAVR Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cerebral Embolic Protection Devices for TAVR Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Cerebral Embolic Protection Devices for TAVR companies in 2021 (%)
The global Cerebral Embolic Protection Devices for TAVR market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Total Artery Coverage Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cerebral Embolic Protection Devices for TAVR include Venus Medtech (Keystone Heart), Boston Scientific (Claret Medical), Transverse Medical, Innovative Cardiovascular Solutions, Protembis GmbH, Filterlex Medical and Emboline, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cerebral Embolic Protection Devices for TAVR manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cerebral Embolic Protection Devices for TAVR Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cerebral Embolic Protection Devices for TAVR Market Segment Percentages, by Type, 2021 (%)
Total Artery Coverage
Non-total Artery Coverage
Global Cerebral Embolic Protection Devices for TAVR Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cerebral Embolic Protection Devices for TAVR Market Segment Percentages, by Application, 2021 (%)
Hospital
Laboratory
Global Cerebral Embolic Protection Devices for TAVR Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cerebral Embolic Protection Devices for TAVR Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cerebral Embolic Protection Devices for TAVR revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cerebral Embolic Protection Devices for TAVR revenues share in global market, 2021 (%)
Key companies Cerebral Embolic Protection Devices for TAVR sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Cerebral Embolic Protection Devices for TAVR sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Venus Medtech (Keystone Heart)
Boston Scientific (Claret Medical)
Transverse Medical
Innovative Cardiovascular Solutions
Protembis GmbH
Filterlex Medical
Emboline